Status:
COMPLETED
Efficacy and Safety of R-hLH (Luveris ®) Priming Prior to R-HFSH Treatment in Infertile Women Undergoing IVF-ET
Lead Sponsor:
NHS Greater Glasgow and Clyde
Conditions:
Infertility
Eligibility:
FEMALE
19-37 years
Phase:
PHASE4
Brief Summary
In programmes of IVF, normal women undergo controlled ovarian stimulation using exogenous FSH injections to obtain multiple eggs. The process results in eggs of mixed quality with a broad range of dev...
Detailed Description
Normal women undergoing IVF (Total n = 146; GRI n = 43) were recruited in 4 centres in 3 countries, and all were started on treatment with a depo GnRH-agonist to suppress endogenous gonadotropin secre...
Eligibility Criteria
Inclusion
- infertile undergoing IVF
- normal menstrual rhythm
Exclusion
- polycystic ovaries
- known resistance to FSH
- other drug preparations
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
End Date :
February 1 2006
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00441324
Start Date
March 1 2003
End Date
February 1 2006
Last Update
February 28 2007
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Fertility Clinic, Department of Obstetrics and Gynaecology, University Hospital of Odense, 5000
Odense, Denmark
2
Reproductive Medicine Unit, Department of Gynaecology and Obstetrics, Jean Verdier Hospital, University Paris XIII
Paris, France
3
Assisted Conception Unit., Royal Infirmary of Edinburgh
Edinburgh, United Kingdom